Older patients may be spared dementia and falls by a new NHS tech roll-out, via digital checks that aim to save lives through diagnosis of sepsis, and other tools being made available in hospitals across the country as part of the NHS Long Term Plan.
The National Institute for Health and Care Excellence (NICE) is working with the Canadian Agency for Drugs and Technology in Health (CADTH) to offer parallel scientific advice to the life sciences industry.
The US Food and Drug Administration (FDA) has approved Sanofi's Cablivi as the first treatment for adult patients with a rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP).
GlaxoSmithKline (GSK) has released its fourth-quarter 2018 results, reporting prescription drug sales of £4.8 billion - a 6% increase on the prior year period - and profit of £1.4 billion, marking an increase of £442 million.
Zogenix has completed its rolling submission of a New Drug Application in the US and submitted a marketing application in Europe for Fintepla for the treatment of seizures associated with Dravet syndrome.
Roche has announced that it has joined the World Federation of Hemophilia (WFH) Humanitarian Aid Program, a landmark initiative leading the effort to change the lack of access to care and treatment for people with inherited bleeding disorders in developing countries.